Concurrent hyperreactive malarial splenomegaly and quartan malarial nephropathy - Plasmodium malariae revisited

Randomized Phase 3 study of pomalidomide cyclophosphamide dexamethasone versus pomalidomide dexamethasone in relapse or refractory myeloma: an Asian Myeloma Network study (AMN003).

Blood cancer journal·2025

The functional role of surface molecules on extracellular vesicles in cancer, autoimmune diseases, and coagulopathy.

Journal of leukocyte biology·2020

Correction: Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond.

Leukemia·2019

Multiple myeloma in patients up to 30 years of age: a multicenter retrospective study of 52 cases.

Leukemia & lymphoma·2018

Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond.

Leukemia·2017

Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group.

Leukemia·2015

Decreasing excess mortality after allogeneic stem cell transplantation for acute leukemia.

Haematologica·2026

Risks and benefits of gene therapy and transplantation in sickle cell disease. Comment on: "HLA-haploidentical hematopoietic stem cell transplantation in patients with sickle cell disease: results from the phase II DREP-HAPLO trial"

Haematologica·2026

Balancing remission durability and treatment burden in older acute myeloid leukemia. Comment on: "Long-term follow-up of oral decitabine/cedazuridine plus venetoclax for older or unfit patients with newly diagnosed acute myeloid leukemia".

Haematologica·2026

Separating dose schedule from disease biology in CD19 CAR T-cell therapy. Comment on: "A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma".

Haematologica·2026

Safety, feasibility, and efficacy of anti-PD-1 therapy for the treatment of classical Hodgkin lymphoma.

Haematologica·2026

Defining the therapeutic window of NLRP6 modulation in graft-versus-host disease. Comment on: "NLRP6 regulates donor T cell activation and acute graft-versus-host disease via ZAP-70-Erk pathway".

Haematologica·2026

Malaria Transmission Via Needle Stick Injury: A Case Report and Systematic Review of the Literature.

The Pediatric infectious disease journal·2026

Remimazolam vs midazolam for sedation in upper gastrointestinal endoscopy: a systematic review and meta-analysis.

Naunyn-Schmiedeberg's archives of pharmacology·2026

Frequent Oropharyngeal Detection of Treponema pallidum DNA in Patients with Syphilis: A Cross-Sectional Study of Three Anatomical Sampling Sites.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026

Brucellosis with Multisystem Involvement: A Case Report Focusing on Neurological Manifestations and Drug-Induced Dermatitis-Diagnostic and Therapeutic Dilemmas.

Infection and drug resistance·2026

Experimental validation of a computationally designed mosquito midgut SGU protein-based epitope vaccine against malaria.

Developmental and comparative immunology·2026

Not Your Everyday Toe Abscess: The Curious Case of Phaeoacremonium parasiticum in a Healthy Host.

Indian journal of medical microbiology·2026

Related Experiment Videos

Concurrent hyperreactive malarial splenomegaly and quartan malarial nephropathy - Plasmodium malariae revisited

Related Concept Videos

Randomized Phase 3 study of pomalidomide cyclophosphamide dexamethasone versus pomalidomide dexamethasone in relapse or refractory myeloma: an Asian Myeloma Network study (AMN003).

The functional role of surface molecules on extracellular vesicles in cancer, autoimmune diseases, and coagulopathy.

Correction: Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond.

Multiple myeloma in patients up to 30 years of age: a multicenter retrospective study of 52 cases.

Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond.

Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group.

Decreasing excess mortality after allogeneic stem cell transplantation for acute leukemia.

Risks and benefits of gene therapy and transplantation in sickle cell disease. Comment on: "HLA-haploidentical hematopoietic stem cell transplantation in patients with sickle cell disease: results from the phase II DREP-HAPLO trial"

Balancing remission durability and treatment burden in older acute myeloid leukemia. Comment on: "Long-term follow-up of oral decitabine/cedazuridine plus venetoclax for older or unfit patients with newly diagnosed acute myeloid leukemia".

Separating dose schedule from disease biology in CD19 CAR T-cell therapy. Comment on: "A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma".

Safety, feasibility, and efficacy of anti-PD-1 therapy for the treatment of classical Hodgkin lymphoma.

Defining the therapeutic window of NLRP6 modulation in graft-versus-host disease. Comment on: "NLRP6 regulates donor T cell activation and acute graft-versus-host disease via ZAP-70-Erk pathway".

Malaria Transmission Via Needle Stick Injury: A Case Report and Systematic Review of the Literature.

Remimazolam vs midazolam for sedation in upper gastrointestinal endoscopy: a systematic review and meta-analysis.

Frequent Oropharyngeal Detection of Treponema pallidum DNA in Patients with Syphilis: A Cross-Sectional Study of Three Anatomical Sampling Sites.

Brucellosis with Multisystem Involvement: A Case Report Focusing on Neurological Manifestations and Drug-Induced Dermatitis-Diagnostic and Therapeutic Dilemmas.

Experimental validation of a computationally designed mosquito midgut SGU protein-based epitope vaccine against malaria.

Not Your Everyday Toe Abscess: The Curious Case of Phaeoacremonium parasiticum in a Healthy Host.

Related Experiment Videos

Concurrent hyperreactive malarial splenomegaly and quartan malarial nephropathy - Plasmodium malariae revisited

Related Concept Videos

Related Articles